The greatest biological diversity on the planet, combined with advanced science and the current legal structure in Brazil, offers a unique opportunity for developing innovative treatments for unmet global medical needs. 


Bionovis, a joint venture in pharmaceutical biotechnology formed by Aché and three other companies from the Brazilian pharmaceutical market, promotes research and development, and the production and marketing of biopharmaceuticals in Brazil, where it is a pioneer in the production of highly complex biological medicines. Based on a combination of public and private efforts, and following the most rigorous scientific, technical and ethical standards, over the next few years it is going to be possible to expand the access of Brazilians to highly complex biopharmaceuticals and to develop innovative medicines for Brazil and the world.